NASDAQ:APDN - Applied DNA Sciences Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.80 +0.01 (+1.27 %)
(As of 12/19/2018 02:59 AM ET)
Previous Close$0.79
Today's Range$0.76 - $0.82
52-Week Range$0.75 - $2.25
Volume89,000 shs
Average Volume104,884 shs
Market Capitalization$27.10 million
P/E RatioN/A
Dividend YieldN/A
Applied DNA Sciences, Inc. provides biotechnology based security solutions for supply chain security, brand protection, and law enforcement applications in the United States, Europe, Asia, and internationally. The company's supply chain security and product authentication solutions include SigNature molecular tags that are ingredients used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNature T molecular tags, which are tagging and authentication systems for use in brand protection efforts and raw material source compliance programs; and fiberTyping, a test of native cotton fiber DNA. It also provides DNAnet, a DNA marker to link evidence and offenders to specific crime scenes; Beacon locked optical markers, which create a protected covert screening tool that can be adapted to packaging, security labels, and high–value assets through inks, varnishes, and coatings; and SigNify IF portable DNA reader that provides real-time authentication of in the field–DNA. In addition, the company offers digitalDNA, a software platform to manage the security of company-marked goods from point of marking to point of authentication or validation to end of life; and DNA Transfer Systems, which offer remote Internet access for real-time monitoring. Further, it provides CertainT Supply Chain Platform that provides proof of product claims for materials, items, or products; and Triathlon PCR systems that allow for the large-scale production of specific DNA sequences. Applied DNA Sciences, Inc. has a cooperative research and development agreement with the U.S. Army Research, Development and Engineering Command's Edgewood Chemical Biological Center; and a collaboration agreement with Colorcon, Inc. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.

Receive APDN News and Ratings via Email

Sign-up to receive the latest news and ratings for APDN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Miscellaneous business services
SectorIndustrial Products
Current SymbolNASDAQ:APDN
Previous Symbol


Debt-to-Equity RatioN/A
Current Ratio1.55
Quick Ratio1.46


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$3.90 million
Price / Sales6.18
Cash FlowN/A
Price / Cash FlowN/A
Book Value$0.25 per share
Price / Book3.20


EPS (Most Recent Fiscal Year)N/A
Net Income$-11,700,000.00
Net Margins-299.85%
Return on Equity-208.26%
Return on Assets-145.69%


Outstanding Shares30,110,000
Market Cap$27.10 million

Applied DNA Sciences (NASDAQ:APDN) Frequently Asked Questions

What is Applied DNA Sciences' stock symbol?

Applied DNA Sciences trades on the NASDAQ under the ticker symbol "APDN."

How were Applied DNA Sciences' earnings last quarter?

Applied DNA Sciences Inc (NASDAQ:APDN) issued its quarterly earnings data on Thursday, December, 13th. The technology company reported ($0.12) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.04) by $0.08. The technology company had revenue of $1.20 million for the quarter. Applied DNA Sciences had a negative return on equity of 208.26% and a negative net margin of 299.85%. View Applied DNA Sciences' Earnings History.

When is Applied DNA Sciences' next earnings date?

Applied DNA Sciences is scheduled to release their next quarterly earnings announcement on Thursday, February 14th 2019. View Earnings Estimates for Applied DNA Sciences.

What price target have analysts set for APDN?

1 equities research analysts have issued 1 year target prices for Applied DNA Sciences' shares. Their predictions range from $3.00 to $3.00. On average, they anticipate Applied DNA Sciences' share price to reach $3.00 in the next twelve months. This suggests a possible upside of 275.0% from the stock's current price. View Analyst Price Targets for Applied DNA Sciences.

What is the consensus analysts' recommendation for Applied DNA Sciences?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Applied DNA Sciences in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Applied DNA Sciences.

Has Applied DNA Sciences been receiving favorable news coverage?

News stories about APDN stock have trended somewhat positive on Wednesday, InfoTrie reports. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Applied DNA Sciences earned a news impact score of 1.3 on InfoTrie's scale. They also gave media headlines about the technology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term.

Who are some of Applied DNA Sciences' key competitors?

Who are Applied DNA Sciences' key executives?

Applied DNA Sciences' management team includes the folowing people:
  • Dr. James A. Hayward, Pres, CEO & Chairman (Age 64)
  • Ms. Beth M. Jantzen CPA, CFO & Principal Accounting Officer (Age 42)
  • Ms. Judith Murrah, Chief Information Officer & Sec. (Age 60)
  • Mr. Tony Benson, Managing Director of EMEA
  • Mr. Steve Birkhold, Chief Exec. Officer of UL Brands

Who are Applied DNA Sciences' major shareholders?

Applied DNA Sciences' stock is owned by a number of of retail and institutional investors. Top institutional investors include Vanguard Group Inc (2.48%) and Chase Investment Counsel Corp (0.44%). View Institutional Ownership Trends for Applied DNA Sciences.

Which institutional investors are buying Applied DNA Sciences stock?

APDN stock was acquired by a variety of institutional investors in the last quarter, including Chase Investment Counsel Corp and Vanguard Group Inc. View Insider Buying and Selling for Applied DNA Sciences.

How do I buy shares of Applied DNA Sciences?

Shares of APDN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Applied DNA Sciences' stock price today?

One share of APDN stock can currently be purchased for approximately $0.80.

How big of a company is Applied DNA Sciences?

Applied DNA Sciences has a market capitalization of $27.10 million and generates $3.90 million in revenue each year. Applied DNA Sciences employs 57 workers across the globe.

What is Applied DNA Sciences' official website?

The official website for Applied DNA Sciences is

How can I contact Applied DNA Sciences?

Applied DNA Sciences' mailing address is 50 HEALTH SCIENCES DRIVE, STONY BROOK NY, 11790. The technology company can be reached via phone at 631-840-8800 or via email at [email protected]

MarketBeat Community Rating for Applied DNA Sciences (NASDAQ APDN)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  144 (Vote Outperform)
Underperform Votes:  100 (Vote Underperform)
Total Votes:  244
MarketBeat's community ratings are surveys of what our community members think about Applied DNA Sciences and other stocks. Vote "Outperform" if you believe APDN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe APDN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/19/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel